ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

IB

Imviva Bio at ACR Convergence 2026

Nov 6–11, 2026 Orlando, FL ~15k attendees Website

Imviva Bio brings 4 presentations to ACR Convergence 2026 in Orlando. Its program centres on dual CD19/BCMA allogeneic CAR-T cell therapy for lupus and lupus nephritis, including deep B-cell depletion, immune reset and durable remission in refractory disease.

OrganizationACR Convergence 2026 Attendance
IB
Imviva Bio
Biotech companies
A biotechnology company developing allogeneic CAR T-cell therapies for autoimmune diseases.

Explore the full ACR Convergence 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Orlando. Leave your work email and we’ll be in touch.

Privacy

Download the full ACR Convergence 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Imviva Bio

Tell us what you sell and we’ll find the people at Imviva Bio most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction